146 related articles for article (PubMed ID: 3439426)
1. Radioreceptor assay in checking serum concentration in long-term treatment with cis(z)-flupenthixol decanoate.
Lipska B; Welbel L; Nurowska K; Szukalski B
Act Nerv Super (Praha); 1987 Dec; 29(4):270-3. PubMed ID: 3439426
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
Turbott J; Villiger J; Hunter L
Br J Psychiatry; 1985 Apr; 146():439-42. PubMed ID: 4016448
[TBL] [Abstract][Full Text] [Related]
3. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Kong DS; Yeo SH
Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum levels after intramuscular injections of 2% and 10% cis(Z)-flupentixol decanoate in Viscoleo to schizophrenic patients.
Stauning JA; Kirk L; Jøorgensen A
Psychopharmacology (Berl); 1979 Sep; 65(1):69-72. PubMed ID: 116292
[TBL] [Abstract][Full Text] [Related]
5. [Dose and serum drug level and its clinical effects during the long-term treatment of chronic schizophrenia with flupenthixol depot].
Lipska B; Szukalski B; Nurowska K; Welbel L
Psychiatr Pol; 1986; 20(1):1-7. PubMed ID: 3725983
[No Abstract] [Full Text] [Related]
6. Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate.
Jørgensen A; Andersen J; Bjørndal N; Dencker SJ; Lundin L; Malm U
Psychopharmacology (Berl); 1982; 77(1):58-65. PubMed ID: 6812119
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the long acting neuroleptic agent flupenthixol decanoate--a review (author's transl)].
Sieberns S
Pharmakopsychiatr Neuropsychopharmakol; 1978 Jul; 11(4):186-98. PubMed ID: 674354
[TBL] [Abstract][Full Text] [Related]
8. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
Turbott J; Villiger J; Hunter L
Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
[TBL] [Abstract][Full Text] [Related]
9. Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose.
Kistrup K; Gerlach J; Aaes-Jørgensen T; Larsen NE
Psychopharmacology (Berl); 1991; 105(1):42-8. PubMed ID: 1745710
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison.
Eberhard G; Hellbom E
Acta Psychiatr Scand; 1986 Sep; 74(3):255-62. PubMed ID: 3788652
[TBL] [Abstract][Full Text] [Related]
11. Steady-state serum concentrations after cis (Z)-flupentixol decanoate in viscoleo.
Saikia JK; Jørgensen A
Psychopharmacology (Berl); 1983; 80(4):371-3. PubMed ID: 6414008
[TBL] [Abstract][Full Text] [Related]
12. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
Jrgensen A; Overø KF
Acta Psychiatr Scand Suppl; 1980; 279():41-54. PubMed ID: 6931472
[TBL] [Abstract][Full Text] [Related]
13. Flupentixol and flupentixol decanoate, with special reference to their antipsychotic effect.
Gottfries CG
Acta Psychiatr Belg; 1974 Sep; 74(5):507-16. PubMed ID: 4620362
[No Abstract] [Full Text] [Related]
14. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
Kong DS; Yeo SH
Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
[No Abstract] [Full Text] [Related]
15. Neuroleptic radioreceptor activity and clinical outcome in schizophrenia.
Contreras S; Alexander H; Faber R; Bowden C
J Clin Psychopharmacol; 1987 Apr; 7(2):95-8. PubMed ID: 3584527
[TBL] [Abstract][Full Text] [Related]
16. High dose flupenthixol decanoate in chronic schizophrenia.
McCreadie RG; Flanagan WL; McKnight J; Jorgensen A
Br J Psychiatry; 1979 Aug; 135():175-9. PubMed ID: 387151
[TBL] [Abstract][Full Text] [Related]
17. The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regime.
Cookson IB
Int Clin Psychopharmacol; 1987 Apr; 2(2):141-9. PubMed ID: 3298419
[TBL] [Abstract][Full Text] [Related]
18. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome.
Dencker SJ; Malm U; Jørgensen A; Overø KF
Acta Psychiatr Scand Suppl; 1980; 279():55-63. PubMed ID: 6931473
[TBL] [Abstract][Full Text] [Related]
19. Peroral and parenteral administration of long-acting neuroleptics: a double-blind study of penfluridol compared to flupenthixol decanoate in the treatment of schizophrenia.
Gerlach J; Kramp P; Kristjansen P; Lauritsen B; Lühdorf K; Munkvad I
Acta Psychiatr Scand; 1975 Aug; 52(2):132-44. PubMed ID: 1096541
[TBL] [Abstract][Full Text] [Related]
20. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
Brown WA; Silver MA
J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]